# Syra Health Corp. Class A Common Stock (SYRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SYRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 4.67M | $ 491.2K | $ 643.2K | $ 149.3K | $ 2.63M |
| 2025 | $ 7.40M | $ -917.8K | $ -458.6K | $ 143.8K | $ 2.10M |
| 2024 | $ 8.39M | $ -3.95M | $ -3.09M | $ 452.1K | $ 2.88M |
| 2023 | $ 5.96M | $ -3.18M | $ -3.00M | $ 248.1K | $ 4.01M |
| 2022 | $ 6.28M | $ -2.37M | $ -2.64M | $ 934.8K | $ 710.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 0.45 |
| Current Ratio | 3.13 |

## Other views

- [Metrics](https://sponda.capital/en/SYRA.md)
- [Charts](https://sponda.capital/en/SYRA/charts.md)
- [Compare](https://sponda.capital/en/SYRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.